Canada markets open in 2 hours 53 minutes

Emmaus Life Sciences, Inc. (EMMA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1170+0.0270 (+30.00%)
At close: 02:30PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.28M
Enterprise Value 40.11M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.21
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.41
Enterprise Value/EBITDA 19.67

Trading Information

Stock Price History

Beta (5Y Monthly) 1.72
52-Week Change 3-64.55%
S&P500 52-Week Change 329.57%
52 Week High 30.3540
52 Week Low 30.0510
50-Day Moving Average 30.1068
200-Day Moving Average 30.1474

Share Statistics

Avg Vol (3 month) 319.59k
Avg Vol (10 day) 36.26k
Shares Outstanding 553.64M
Implied Shares Outstanding 653.64M
Float 829.02M
% Held by Insiders 151.77%
% Held by Institutions 10.08%
Shares Short (Aug 15, 2019) 441.22k
Short Ratio (Aug 15, 2019) 40.48
Short % of Float (Aug 15, 2019) 40.09%
Short % of Shares Outstanding (Aug 15, 2019) 40.09%
Shares Short (prior month Jun 28, 2019) 433.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 18, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 18, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -16.66%
Operating Margin (ttm)0.48%

Management Effectiveness

Return on Assets (ttm)1.07%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)28.46M
Revenue Per Share (ttm)0.55
Quarterly Revenue Growth (yoy)1.60%
Gross Profit (ttm)N/A
EBITDA 806k
Net Income Avi to Common (ttm)-4.74M
Diluted EPS (ttm)-0.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.5M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)34.09M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.15
Book Value Per Share (mrq)-0.68

Cash Flow Statement

Operating Cash Flow (ttm)-862k
Levered Free Cash Flow (ttm)12.53M